Collegium Pharmaceutical (COLL) Net Margin (2016 - 2026)

Collegium Pharmaceutical's Net Margin history runs 11 years deep, the most recent figure standing at 7.49% for Q1 2026.

• In Q1 2026, Net Margin rose 613.0% year-over-year to 7.49%; the TTM figure through Mar 2026 stood at 9.41% (up 85.0% YoY), while the FY2025 annual figure was 8.05%, down 290.0% from the prior year.
• Net Margin was 7.49% for Q1 2026 at Collegium Pharmaceutical, down from 8.26% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 117.26% in Q3 2024 to a low of 359.53% in Q1 2022.
• Historically, Net Margin has averaged 8.21% across 5 years, with a median of 7.49% in 2026.
• The sharpest annual moves came in 2022 and 2023: Net Margin plunged 37871 bps in 2022, then soared 34750 bps in 2023.
• A 5-year view of Net Margin shows it stood at 5.55% in 2022, then soared by 484 bps to 21.33% in 2023, then slumped by 68 bps to 6.89% in 2024, then climbed by 20 bps to 8.26% in 2025, then slipped by 9 bps to 7.49% in 2026.
• The last three Net Margin figures came in at 7.49% (Q1 2026), 8.26% (Q4 2025), and 15.05% (Q3 2025), per Business Quant data.